A review on an ayurvedic antimalarial drug: Ayush-64

Abstract

Ayurveda is one of the oldest medicinal systems in the world, derived from ancient texts that emphasize a "natural" and holistic approach to physical and mental well-being. Ayurveda is still practiced in traditional Indian healthcare. A parasite that is prevalent in tropical regions is the cause of malaria. The kind of mosquito that spreads malaria from person to person is called Anopheles. Fever, chills, and a flulike illness are common symptoms in those suffering from malaria. Plasmodium falciparum, P. ovale, P. malariae, and P. vivax are the four species that cause the disease. The latter three species may remain in the liver and can cause relapse many years after the initial infection, although they are not as harmful as P. falciparum. For thousands of years, people have been treating malaria with plants. Quinine was used as the dominant antimalarial medication for many years, but since the 1930s, several synthetic medications have essentially taken the position of these medications. The Ayurvedic formulation Ayush-64 was developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), which is the highest authority for Ayurvedic research under the Ministry of Ayush. Since the 1980s, CCRAS peripheral institutes have been using it to treat a variety of illnesses, including inflammations, fevers, and joint difficulties. Its effectiveness in treating diseases including chikungunya, microfilaria, and the malarial fever has been documented. Ayush-64 is useful in treating asymptomatic, mild-to-moderate instances of COVID-19 illness, according to several trials. In short, Ayush-64 can be said addressed rightly as a miraculous boon from the field of Ayurveda to society.